Drugs / G-CSF mobilized peripheral blood cells
G-CSF mobilized peripheral blood cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02587871 | Dec 2018 → Nov 2020 | childhood acute myeloid leukemia | University of Southern California | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF mobilized peripheral blood cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02587871 ↗ |
| Modality | Cell therapy | “Donor cellular therapy is a short-term transfusion of cells from a family member who is incompletely matched.” NCT02587871 ↗ |
| Route | Intravenous | “G-CSF mobilized peripheral blood cells (microtransplant) IV over 15-20 minutes on day 0.” NCT02587871 ↗ |